Pfizer Antiviral Drug 89% Effective

This morning, Pfizer said it’s experimental pill which was designed to fight Covid-19 reduced the risk of hospitalization and death for high-risk patients taking part in a trial. The company hopes to offer the pill in combination with the antiviral drug Ritonavir to people to take at home before they get sick enough to require hospitalization. Pfizer released the results of an analysis which showed an 89% reduction in the risk of hospitalization or death from Covid-19 if the patents got the pill soon enough. The company did not provide scientists to discuss the data which has yet to be peer reviewed or published. They’re expected to share more specifics in a peer-reviewed paper and with it’s submission to the FDA.